» Articles » PMID: 28758902

GATA4 Loss of Function in Liver Cancer Impedes Precursor to Hepatocyte Transition

Abstract

The most frequent chromosomal structural loss in hepatocellular carcinoma (HCC) is of the short arm of chromosome 8 (8p). Genes on the remaining homologous chromosome, however, are not recurrently mutated, and the identity of key 8p tumor-suppressor genes (TSG) is unknown. In this work, analysis of minimal commonly deleted 8p segments to identify candidate TSG implicated GATA4, a master transcription factor driver of hepatocyte epithelial lineage fate. In a murine model, liver-conditional deletion of 1 Gata4 allele to model the haploinsufficiency seen in HCC produced enlarged livers with a gene expression profile of persistent precursor proliferation and failed hepatocyte epithelial differentiation. HCC mimicked this gene expression profile, even in cases that were morphologically classified as well differentiated. HCC with intact chromosome 8p also featured GATA4 loss of function via GATA4 germline mutations that abrogated GATA4 interactions with a coactivator, MED12, or by inactivating mutations directly in GATA4 coactivators, including ARID1A. GATA4 reintroduction into GATA4-haploinsufficient HCC cells or ARID1A reintroduction into ARID1A-mutant/GATA4-intact HCC cells activated hundreds of hepatocyte genes and quenched the proliferative precursor program. Thus, disruption of GATA4-mediated transactivation in HCC suppresses hepatocyte epithelial differentiation to sustain replicative precursor phenotype.

Citing Articles

Targeting senescence and GATA4 in age-related cardiovascular disease: a comprehensive approach.

Imran M, Altamimi A, Afzal M, Babu M, Goyal K, Ballal S Biogerontology. 2025; 26(1):45.

PMID: 39831933 DOI: 10.1007/s10522-025-10189-z.


GATA4 downregulation enhances CCL20-mediated immunosuppression in hepatocellular carcinoma.

Nasir N, Chuah S, Shuen T, Prawira A, Ba R, Lim M Hepatol Commun. 2024; 8(9).

PMID: 39167427 PMC: 11340929. DOI: 10.1097/HC9.0000000000000508.


CCDC25 suppresses clear cell renal cell carcinoma progression by LATS1/YAP-mediated regulation of the hippo pathway.

Tan H, Liu J, Li Y, Mi Z, Liu B, Rong P Cancer Cell Int. 2024; 24(1):124.

PMID: 38570766 PMC: 10988808. DOI: 10.1186/s12935-024-03318-0.


Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis.

Gao B, Wu X, Bu L, Jiang Q, Wang L, Liu H Sci Adv. 2024; 10(6):eadk2285.

PMID: 38324694 PMC: 10849599. DOI: 10.1126/sciadv.adk2285.


Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma.

Deutzmann A, Sullivan D, Dhanasekaran R, Li W, Chen X, Tong L Nat Commun. 2024; 15(1):963.

PMID: 38302473 PMC: 10834515. DOI: 10.1038/s41467-024-45128-y.


References
1.
Parviz F, Matullo C, Garrison W, Savatski L, Adamson J, Ning G . Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet. 2003; 34(3):292-6. DOI: 10.1038/ng1175. View

2.
Wang E, Sun S, Qiao B, Duan W, Huang G, An Y . Identification of functional mutations in GATA4 in patients with congenital heart disease. PLoS One. 2013; 8(4):e62138. PMC: 3633926. DOI: 10.1371/journal.pone.0062138. View

3.
Velcheti V, Radivoyevitch T, Saunthararajah Y . Higher-Level Pathway Objectives of Epigenetic Therapy: A Solution to the p53 Problem in Cancer. Am Soc Clin Oncol Educ Book. 2017; 37:812-824. DOI: 10.1200/EDBK_174175. View

4.
Kohn-Gaone J, Gogoi-Tiwari J, Ramm G, Olynyk J, Tirnitz-Parker J . The role of liver progenitor cells during liver regeneration, fibrogenesis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2015; 310(3):G143-54. DOI: 10.1152/ajpgi.00215.2015. View

5.
Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, HORII I . Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 1996; 85(5):707-20. DOI: 10.1016/s0092-8674(00)81237-4. View